INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 12 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,903,450 | +22.6% | 5,000,000 | 0.0% | 0.02% | +25.0% |
Q2 2023 | $3,998,350 | -3.8% | 5,000,000 | 0.0% | 0.02% | 0.0% |
Q1 2023 | $4,156,550 | +9.8% | 5,000,000 | 0.0% | 0.02% | +11.1% |
Q4 2022 | $3,784,450 | +0.2% | 5,000,000 | 0.0% | 0.02% | +5.9% |
Q3 2022 | $3,777,000 | +17.7% | 5,000,000 | 0.0% | 0.02% | +21.4% |
Q2 2022 | $3,209,000 | +4.6% | 5,000,000 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $3,068,000 | +1.9% | 5,000,000 | 0.0% | 0.01% | +9.1% |
Q4 2021 | $3,012,000 | -0.6% | 5,000,000 | 0.0% | 0.01% | -15.4% |
Q3 2021 | $3,030,000 | -11.4% | 5,000,000 | 0.0% | 0.01% | -18.8% |
Q2 2021 | $3,421,000 | +6.2% | 5,000,000 | 0.0% | 0.02% | -11.1% |
Q1 2021 | $3,220,000 | +6.1% | 5,000,000 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $3,036,000 | -12.4% | 5,000,000 | 0.0% | 0.02% | -18.2% |
Q3 2020 | $3,465,000 | -3.8% | 5,000,000 | 0.0% | 0.02% | -12.0% |
Q2 2020 | $3,602,000 | -17.1% | 5,000,000 | 0.0% | 0.02% | -26.5% |
Q1 2020 | $4,345,000 | -34.7% | 5,000,000 | 0.0% | 0.03% | +3.0% |
Q4 2019 | $6,649,000 | +46.6% | 5,000,000 | 0.0% | 0.03% | +32.0% |
Q3 2019 | $4,537,000 | -9.2% | 5,000,000 | 0.0% | 0.02% | -10.7% |
Q2 2019 | $4,998,000 | – | 5,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 5,814,000 | $5,191,000 | 3.20% |
DLD Asset Management, LP | 12,500,000 | $11,219,000 | 0.70% |
Senvest Management, LLC | 5,000,000 | $4,345,000 | 0.51% |
Context Capital Management, LLC | 985,000 | $863,000 | 0.49% |
LINDEN ADVISORS LP | 30,755,000 | $26,983,000 | 0.48% |
SSI INVESTMENT MANAGEMENT LLC | 5,896,000 | $5,014,000 | 0.44% |
BOOTHBAY FUND MANAGEMENT, LLC | 4,386,000 | $3,812,000 | 0.32% |
ADVENT CAPITAL MANAGEMENT /DE/ | 16,582,000 | $14,449,000 | 0.31% |
CSS LLC/IL | 3,825,000 | $3,410,000 | 0.27% |
Polar Asset Management Partners Inc. | 13,000,000 | $11,372,000 | 0.23% |